188 related articles for article (PubMed ID: 37731630)
1. Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings.
Midya A; Hiremath A; Huber J; Sankar Viswanathan V; Omil-Lima D; Mahran A; Bittencourt LK; Harsha Tirumani S; Ponsky L; Shiradkar R; Madabhushi A
Front Oncol; 2023; 13():1166047. PubMed ID: 37731630
[TBL] [Abstract][Full Text] [Related]
2. Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
Algohary A; Viswanath S; Shiradkar R; Ghose S; Pahwa S; Moses D; Jambor I; Shnier R; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Purysko AS; Verma S; Ponsky L; Stricker P; Madabhushi A
J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29469937
[TBL] [Abstract][Full Text] [Related]
3. Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781640
[No Abstract] [Full Text] [Related]
4. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
[TBL] [Abstract][Full Text] [Related]
5. The role of [
Basso Dias A; Mirshahvalad SA; Ortega C; Perlis N; Berlin A; van der Kwast T; Ghai S; Jhaveri K; Metser U; Haider M; Avery L; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2167-2176. PubMed ID: 36809425
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies.
Qi Y; Zhang S; Wei J; Zhang G; Lei J; Yan W; Xiao Y; Yan S; Xue H; Feng F; Sun H; Tian J; Jin Z
J Magn Reson Imaging; 2020 Jun; 51(6):1890-1899. PubMed ID: 31808980
[TBL] [Abstract][Full Text] [Related]
7. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
8. Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL.
Lu Y; Li B; Huang H; Leng Q; Wang Q; Zhong R; Huang Y; Li C; Yuan R; Zhang Y
Front Oncol; 2022; 12():1020317. PubMed ID: 36582803
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
10. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
11. The added value of PSMA PET/MR radiomics for prostate cancer staging.
Solari EL; Gafita A; Schachoff S; Bogdanović B; Villagrán Asiares A; Amiel T; Hui W; Rauscher I; Visvikis D; Maurer T; Schwamborn K; Mustafa M; Weber W; Navab N; Eiber M; Hatt M; Nekolla SG
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):527-538. PubMed ID: 34255130
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance.
Sushentsev N; Rundo L; Blyuss O; Nazarenko T; Suvorov A; Gnanapragasam VJ; Sala E; Barrett T
Eur Radiol; 2022 Jan; 32(1):680-689. PubMed ID: 34255161
[TBL] [Abstract][Full Text] [Related]
13. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
15. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer.
Lorenz JW; Schott D; Rein L; Mostafaei F; Noid G; Lawton C; Bedi M; Li XA; Schultz CJ; Paulson E; Hall WA
Cureus; 2019 Apr; 11(4):e4510. PubMed ID: 31259119
[TBL] [Abstract][Full Text] [Related]
16. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
17. MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies.
Zhang L; Zhang J; Tang M; Lei XY; Li LC
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553012
[TBL] [Abstract][Full Text] [Related]
18. Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance.
Sushentsev N; Rundo L; Abrego L; Li Z; Nazarenko T; Warren AY; Gnanapragasam VJ; Sala E; Zaikin A; Barrett T; Blyuss O
Eur Radiol; 2023 Jun; 33(6):3792-3800. PubMed ID: 36749370
[TBL] [Abstract][Full Text] [Related]
19. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
